These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21293540)

  • 1. Calcineurin inhibitor-induced renal allograft nephrotoxicity.
    Krejci K; Tichy T; Bachleda P; Zadrazil J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):297-306. PubMed ID: 21293540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor nephrotoxicity.
    Naesens M; Kuypers DR; Sarwal M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):481-508. PubMed ID: 19218475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment.
    Baran DA; Galin ID; Gass AL
    Am J Cardiovasc Drugs; 2004; 4(1):21-9. PubMed ID: 14967063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.
    Jacquet A; Francois H; Frangie C; Ahmad L; Charpentier B; Durrbach A
    Transpl Immunol; 2008 Nov; 20(1-2):29-31. PubMed ID: 18817870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity.
    Bentata Y
    Artif Organs; 2020 Feb; 44(2):140-152. PubMed ID: 31386765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
    Olyaei AJ; de Mattos AM; Bennett WM
    Curr Opin Crit Care; 2001 Dec; 7(6):384-9. PubMed ID: 11805539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensinogenic mechanism of the calcineurin inhibitors.
    Curtis JJ
    Curr Hypertens Rep; 2002 Oct; 4(5):377-80. PubMed ID: 12217256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
    Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation.
    Yessayan L; Shafiq A; Peterson E; Wells K; Hu Y; Williams LK; Lanfear D
    Transplant Proc; 2015 Dec; 47(10):2968-72. PubMed ID: 26707323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors].
    Nikitin AV
    Antibiot Khimioter; 2014; 59(1-2):44-7. PubMed ID: 25051716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
    Morales JM; Andres A; Rengel M; Rodicio JL
    Nephrol Dial Transplant; 2001; 16 Suppl 1():121-4. PubMed ID: 11369839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.
    de Mattos AM; Olyaei AJ; Bennett WM
    Am J Kidney Dis; 2000 Feb; 35(2):333-46. PubMed ID: 10676738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
    Issa N; Kukla A; Ibrahim HN
    Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.